AVXL
Anavex Life Sciences Corporation
Halal Rating :
Last Price
$9.20
Last updated:
Market Cap
-
7D Change
-12.8%
1 Year Change
39.39%
Company Overview
Industries
Exchange
Next Earnings Date
Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company focused on developing therapeutics for neurodegenerative and neurodevelopmental disorders. Their lead product candidate is ANAVEX®2-73 (blarcamesine), which is being developed for various conditions including Alzheimer's disease, Parkinson's disease, and Rett syndrome.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Anavex Life Sciences Corporation's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.